Study details
Enrolling now
Valacyclovir for Acute Apical Abscess Pain
University of California, San Francisco
NCT IDNCT05266040ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
60
Study length
about 2.2 years
Ages
18–80
Locations
1 site in CA
About this study
Researchers are testing whether valacyclovir helps with pain from acute apical abscesses. The trial will involve 60 adults and last about 798 days. It's looking at how well valacyclovir works compared to a placebo.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Placebo
- 2.Take Valacyclovir 500 MG
PhasePhase 2
DrugValacyclovir 500 MG
Routeoral
Primary goalMeasurement of pain levels following treatment intervention
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low7%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
valaciclovir (Antiviral; prodrug of acyclovir)
Drug routes
oral (Oral Tablet)
Endpoints
Primary: Measurement of pain levels following treatment intervention